Jacobs Levy Equity Management, Inc Kura Oncology, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$7.95 - $18.81 $139,935 - $331,093	-17,602 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $10,707 - $23,306	-1,660 Reduced 8.62%	17,602 $175,000
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $2,594 - $3,188	-200 Reduced 1.03%	19,262 $265,000
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $287,064 - $406,171	19,462 New	19,462 $295,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.